---
category: news
title: "OSE Immunotherapeutics Expands its Collaboration with MAbSilico to Use Artificial Intelligence to Accelerate Drug Development of Novel Antibody Therapeutics"
excerpt: "OSE Immunotherapeutics Expands its Collaboration with MAbSilico to Use Artificial Intelligence to Accelerate Drug Development"
publishedDateTime: 2021-01-28T17:03:00Z
originalUrl: "https://www.businesswire.com/news/home/20210128005756/en/OSE-Immunotherapeutics-Expands-its-Collaboration-with-MAbSilico-to-Use-Artificial-Intelligence-to-Accelerate-Drug-Development-of-Novel-Antibody-Therapeutics"
webUrl: "https://www.businesswire.com/news/home/20210128005756/en/OSE-Immunotherapeutics-Expands-its-Collaboration-with-MAbSilico-to-Use-Artificial-Intelligence-to-Accelerate-Drug-Development-of-Novel-Antibody-Therapeutics"
type: article
quality: 0
heat: 0
published: false

provider:
  name: Business Wire
  domain: businesswire.com

topics:
  - AI

secured: "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;DI8vxghQ+xvnAQd0LWapbg=="
---

